Optical coherence tomography (OCT) is an optical analog of ultrasound imaging that uses low coherence interferometry to produce cross-sectional images of the retina. It captures optical scattering from the tissue to decode spatial details of tissue microstructures. It uses infrared light from a super-luminescent diode that is divided into two parts: one of which is reflected from a reference mirror and the other is scattered from the biological tissue. The two reflected beams of light are made to produce interference patterns to obtain the echo time delay and their amplitude information that makes up an A-Scan. A-Scans that are captured at adjacent retinal locations by transverse scanning mechanism are combined to produce a 2-dimensional image. [1] The stages of evolution of various types of OCT from the original time-domain OCT to spectral domain (SD-OCT) and swept-source OCT (SSOCT) are shown in Fig. 1 and the corresponding images are shown in Fig. 2 . Table 1 is a brief comparison of the salient features of the three types of OCT.
Optical Coherence Tomography Scan Protocols
Scan protocols used in the more widely used SD-OCT systems are mentioned in this section. The commonly used scan protocols for macular scanning are three-dimensional (3D) scan, radial scan, and raster scan [ Fig. 3 ]. A 3D scan consists of a number of horizontal line scans [ Fig. 4 , left] composing a 6 mm × 6 mm or 7 mm × 7 mm or 12 mm × 9 mm rectangular box. It generates a 3D view of the image which enables the implementation of advanced, complex analysis, for example, C-scan, topographic maps, and cyst volume and gives a holistic view of the macula. Raster scan is a series of parallel line scans that can be oriented in any angle and is of higher resolution [ Fig. 4 , right]. The radial scan consists of 6-12 line scans arranged in equal angles with common axis [ Fig. 5 ]. When the axis coincides with the fovea, the relationship of the lesion to the fovea is documented. These scan protocols may differ in length, density, or resolution depending on the OCT system used [ Fig. 6 ].
Optical Coherence Tomography Scan Acquisition Procedure
A minimum pupil diameter of 3 mm is required to obtain a good OCT image. An appropriate scanning protocol is selected to scan the retinal area of interest and a live OCT window is seen. The patient is instructed to look at the internal target at the center (for macular scanning) or an external target where appropriate. Once the fundus image on the monitor is focused, the OCT image appears on the monitor, focus is enabled by correcting refractive errors. Make sure that the OCT image is upright and straight and the reference scan pattern is centered on the fovea or the area of interest. Adjust the light entry point across the pupil to get the best signal strength. Repeat the procedure with other scan protocols if necessary. The saved Bhende, et al.: OCT interpretation of macular diseases 
Measurements
Retinal thickness is a reproducible and common quantitative measurement that is used to monitor the disease process or treatment response using OCT. [2] Every OCT system has an inbuilt segmentation algorithm that identifies the differences in reflectance of the retinal layers and borders and then places lines over the inner and outer border of the retina. The total retinal thickness is the measurement of the distance between these two segmentation lines. Some OCT machines can delineate individual layers of the retina including the outer segments of the photoreceptors and retinal pigment epithelium (RPE). Manual correction of segmentation lines is possible in case of segmentation artifacts and retinal thickness can be measured manually using the inbuilt caliper function. The scan protocols, namely, 3D cube scan and radial scan generates the early treatment diabetic retinopathy study grid with the thickness values displayed in each sector. Central subfield thickness corresponding to the central 1 mm average retinal thickness has high diagnostic value and it correlates with visual acuity. [3] Retinal thickness change between two visits with color coding helps in identifying the absolute change in the areas of thickening/thinning. Comparison of retinal thickness measurements between OCT machines has to be done with caution because of the differences in the placement of segmentation lines that define the retinal thickness. All OCT instruments take the internal limiting membrane as the inner retinal border. The outer retinal border could be any one of the three hyper-reflective outer retinal layers, for example, Spectralis and Cirrus high-definition OCT take the outer most layer, RPE while RTVue takes the inner border of the second hyper-reflective line, the interdigitation zone. [4] Therefore, the normative value for retinal thickness is unique to the machine used and the ethnic background of the subject. [5] Table 2 describes the common terminologies used while measuring the thickness and change of thickness in the macular region. [6] 
Artifacts on Optical Coherence Tomography
OCT artifacts could be patient related, operator-related, and software related. While patient-and operator-related artifacts can be controlled to some extent, software-related errors are inevitable and most common. Patient-related artifacts are mostly due to eye movements, which can be controlled by eye tracking software. Operator-related artifacts include decentered scans, out of registration due to cut images and degraded images due to poor focus. Software-related artifacts are mostly due to failed segmentation algorithms resulting in misidentification of inner, outer retinal boundaries, and incomplete segmentation artifacts. [7] Certain artifacts are associated with a particular disease, for instance, segmentation failure occurs commonly in diseases such as age-related macular degeneration (AMD), vitreomacular traction. [8] Artifacts in the center 1 mm area of scans are infrequent but when present, can affect the center subfield thickness measurements. [9] 
Optical Coherence Tomography Features in Common Macular Disorders
Being noninvasive, quick and reproducible, OCT is used commonly in the diagnosis, and the management of optic nerve and retinal disorders not only for diagnosis but also as a follow-up tool both in clinical practice and in many multicentric trials. Standardized protocols for measurements as well as classic appearances attributable to different structural changes have converted an OCT image into an optical biopsy. The following sections aim to serve as a guide to the OCT features of common retinal conditions along with their relevance in terms of prognosis and also distinguishing features between often misdiagnosed situations. landmarks of identifiable on SD-OCT in the normal macula. [10] As a general guide, based on relative reflectivity, the retinal and choroidal layers are divided into zones (areas which have specific reflective structures but cannot be easily distinguished by clear-cut margins and lack proven histologic evidence for the same) and bands or layers (areas which are discrete and well defined and have a proven histologic correlation). A listing of the zones and their reflectivity are seen in Table 3 . Table 4 lists out the reflectivity of common pathological changes seen on OCT.
Optical Coherence Tomography in Disorders of the Vitreomacular Interface
These include vitreomacular adhesion (VMA), vitreomacular traction (VMT), and macular hole.
The International Vitreomacular Traction Study Group classification is OCT-based and designed to be used as a therapeutic or research guide as well as a possible predictor of treatment outcomes. [11] Perifoveal posterior vitreous detachment with a posterior cortical vitreous attachment within 3 mm of the fovea is considered as VMA if there are no secondary changes in the contour or within the retina. If the area of attachments is ≤1500 µm, it is considered focal and if >1500 µm it is considered broad. [12] All of the following anatomic criteria must appear on at least 1 B-mode OCT scan to classify an eye as having VMT: of attachment with distortion of the foveal surface, intraretinal structural changes, (pseudocysts, macular schisis, cystoid macular edema (CME), and subretinal fluid [SRF]), elevation of the fovea above the RPE, or a combination thereof, but no full-thickness interruption of all retinal layers. [11, 13] Fig. 8 shows the various stages of VMT.
Both VMA and VMT are divided into isolated or concurrent based on the presence or absence of a preexisting retinal condition.
Full-thickness macular holes (FTMH) are defects in the fovea featuring absence of all neural retinal layers from the inner limiting membrane (ILM) to the RPE. These are classified based on their aperture size (minimum hole width) into small (≤250 µm), medium (>250-400 µm), or large (>400 µm) and also based on the presence or absence of VMT [ Fig. 9 ] The concept of measuring the hole size is to predict outcomes after surgery which worsen as the hole size becomes larger. [14] A lamellar hole is a defect where the photoreceptors are intact at the base. This could present with an irregular foveal contour, a defect in the inner foveal layers without actual tissue loss or intraretinal splitting between the outer plexiform and outer nuclear layers (ONLs). [15] Macular pseudohole can be seen as invaginated or heaped foveal edges, Epiretinal membrane (ERM) with central opening, steep macular contour to the central fovea with near-normal central foveal thickness and no tissue loss. [16] 
Optical Coherence Tomography in Choroidal Neovascular Membrane
Well-defined hyperreflective tissue between the RPE/Bruch's membranes (Type 1) or above the RPE (Type 2). [17, 18] [19, 20] The sequence of events in Type 3 is intraretinal followed by subretinal and finally sub-RPE proliferation. pattern is seen with more localized damage to the RPE/ Bruch's membrane complex such as pathologic myopia with lacquer cracks, punctate inner choroidopathy, multifocal choroiditis and panuveitis, and choroidal rupture. It can also be seen in pattern and vitelliform macular dystrophies, ABCA4/Stargardt disease, reticular pseudodrusen, and pseudoxanthomaelasticum. Type 3 neovascularization is mostly seen in neovascular AMD, a similar angiogenic sequence may occur in eyes with macular telangiectasia Type 2 (idiopathic perifoveal telangiectasia). [21] Associated features Certain OCT-derived biomarkers have been identified that could predict the outcomes with treatment and most of these have been derived from AMD related studies. [22, 23] Central retinal thickness is not of as much importance in CNV management as in other conditions as the activity of the lesion has different manifestations in different retinal compartments which have a bearing on the ultimate visual outcome. [24, 25] However, most clinical trials using OCT as a parameter continue to use retinal thickness change as a measure of outcome. [26, 27] Intraretinal cystoid fluid spaces are most often associated with Type 2 or 3 CNV where the lesion is above the RPE. In Type 1 or sub-RPE CNV, the intraretinal fluid appears late in the course of the disease. [21] Exudative intraretinal fluid is seen as large circular or ovoid hyporeflective spaces overlying a pigment epithelial detachment (PED) or a Type 2/3 CNV. These respond well to antivascular endothelial growth factor (VEGF) therapy. However, the presence of intraretinal cystic spaces at baseline is associated with a poorer visual outcome. [28, 29] Degenerative intraretinal fluid is seen as small sharply demarcated hyporeflective spaces in the inner retina overlying areas of RPE atrophy or scarring. [30] These do not respond to anti-VEGF therapy. The intraretinal fluid that persists for more than 12 weeks of anti-VEGF monotherapy is considered degenerative fluid. Similar degenerative changes in the outer retina are referred to as outer retinal tubulations (ORTs) and are discussed subsequently.
SRF is an indicator of activity in all subtypes and is the first sign of activity in Type 1 CNV. The presence of SRF at the start of therapy has been shown to be a favorable sign for visual acuity improvement with therapy. [28, 29] Pigment epithelial detachment There are various subtypes such as serous PED (with clear optically empty sub-RPE space), drusenoid (sub-RPE space is filled with moderately reflective material), fibrovascular (where the sub-RPE space is filled with hyper reflective heterogeneous material) and hemorrhagic (where the surface appears highly reflective with shadowing due to the blood and the deeper layers are not seen) and mixed. [31] Fibrovascular PED is the hallmark of Type 1 CNV with changes in the overlying retina seen only in advanced cases. PED is also a feature of Type 3 CNV where both serous and fibrovascular PEDs are seen. Serous PEDs typically respond well to anti-VEGF therapy. In case of fibrovascular PED (FVPED), the height reduces but typically the neovascular tissue persists, giving rise to recurrences [ Fig. 11 ]. Hence, monitoring of the height of the PED is as important as noting secondary intraretinal or subretinal changes during follow-up.
The subretinal hyperreflective material could represent a Type 2 or 3 CNV but can also contain subretinal hemorrhage, lipid, fibrous tissue, or exudate. The reflectivity of the CNV changes from moderate in the early stage to highly reflective as fibrosis develops. [32] The presence of such material under the fovea is a poor prognostic feature for visual acuity improvement.
Hyperreflective foci in the neurosensory retina form one of the newer, less understood OCT biomarkers in AMD. [32] Their origin is unclear, and they could represent migrating RPE cells, pigment-laden macrophages, microglial cells, or lipid. In early and intermediate AMD, the development of hyperreflective foci could signify conversion to a more advanced stage of atrophic or neovascular AMD [33] [ Fig. 12 ].
ORTs are branching hyporeflective tubular structures with a hyper-reflective border. These represent areas of photoreceptor destruction and are irreversible. [34] The tubulations often overlie a fibrous scar and can be mistaken for intraretinal cystoid spaces. The presence of these findings serve as a negative biomarker in AMD treatment. [22] Retinal pigment epithelial atrophy is identified on OCT by segments of enhanced signals beneath it. [32] It is a negative biomarker for eyes that have atrophy in the presence of active CNV at the start of anti-VEGF therapy. It is seen more commonly in eyes with Type 2 or 3 CNV. The rates of RPE atrophy were shown to be higher in eyes on monthly treatment with anti-VEGF agents in the CATT trial. [35] External limiting membrane and ellipsoid layer integrity have been associated with good visual function in eyes with neovascular AMD. [36] The identification of these outer retinal layers is possible with newer SD-OCT systems. [10] However, their role in predicting visual outcomes after treatment is less well understood.
Choroidal thickness measurements are possible with the advent of enhanced depth imaging and SS imaging. Choroidal thickness reduces with advancing age. The role of choroidal thickness in neovascular AMD is unclear. [37] However, the diseases that come under the pachychoroid spectrum can often mimic neovascular AMD, and hence, the identification of an abnormally thick or thin choroid and detection of pachy vessels assumes importance. [38] [39] [40] 
Vitreomacular interface
Posterior vitreous detachment has been identified as a positive biomarker in patients undergoing treatment for CNV. Eyes with a preexisting posterior vitreous detachment (PVD) have been shown to have a more benign course even with extended treatment intervals as opposed to patients with VMAs that require a more aggressive treatment protocol possibly including surgery. [41] 
Optical Coherence Tomography in Macular Edema
Macular edema causing increased retinal thickness is a common consequence and cause of visual loss in a large number of retinal disorders, most often diabetic retinopathy, neovascular AMD and other causes of CNV, retinal vein occlusions (RVOs), hypertensive retinopathy, central serous chorioretinopathy (CSCR), Irvine-Gass syndrome, pars planitis and other uveitic entities, and retinitis pigmentosa. It may be secondary to traction such as with epiretinal membranes (ERMs) and VMT, drug-induced and overlying intraocular tumors as a sign of activity. [42, 43] It is noted that fundus fluorescein angiography (FFA) leakage in CME is always associated with cystic changes on SD-OCT. Diffuse edema on FFA is more commonly associated with thickening and distortion of the retinal layers without cyst formation though rarely microcystoid changes may be seen on CME. Both situations, however, can coexist [44] Fig. 13 shows the various OCT findings in CME. 
Irvine-Gass syndrome: Pseudophakic cystoid macular edema
In the early stages, the cystoid spaces are seen in the inner nuclear layer (INL), subsequently as severity increases, the outer plexiformlayer (OPL) is involved and in more severe cases, SRF is seen. [43, 44] Diabetic macular edema Macular edema can present as diffuse retinal thickening, cystoid macular edema, tractional, and serous retinal detachment. [45, 46] Diffuse edema is seen as reduced reflectivity of the OPL and INL with an increase in thickness, later on develops a spongy appearance. This is the earliest sign, is associated with good vision and responds best to treatment. CME is characterized by the accumulation of intraretinal fluid in well-defined spaces in the OPL. The arrangement of the Muller fibers as well as the orientation of the Henle's layer contributes to the characteristic appearance. Later, the cysts can coalesce to form larger cavities. The reflectivity of the content of the cysts as well as the size of the cysts is believed to have prognostic value. [47, 48] Serous retinal detachment can occur in the chronic stages or if bilateral, could signify an underlying systemic complication such as nephropathy, multiple myeloma, etc., In contrast to serous retinal detachments which are convex, tractional detachments due to posterior hyaloid attachment and traction have a peaked configuration. OCT can detect macular edema that is not clinically evident, and several OCT-derived biomarkers are useful predictors of progression, severity, and visual outcome. These include retinal nerve fiber layer (RNFL) thickness, central subfield thickness, hyper reflective foci in the outer retina, [49] disorganization of the inner retinal layers DRIL [50] within a 1 mm zone centered on the fovea, ELM and ellipsoid zone disruption [49] and a newer biomarker "parallelism." [51] Figs. 14 and 15 show followup SD-OCT scans of diabetic macular edema (DME) showing reduction and worsening respectively.
Uveitic macular edema
Uveitic macular edema typically involves the INL though later such eyes show similar configuration on OCT as in DME with additional changes due to proliferative retinopathy, vasculitis, traction, or choroidal involvement. [52, 53] Macular edema in CNV It can manifest either as intraretinal fluid, CME, SRF or RPE detachments. The presence of intra or SRF is an indication of activity that requires treatment. RPE detachments alone may not indicate the need for treatment. Cystoid changes can also be present over long-standing fibrotic lesions. The main role of OCT is to identify small changes in activity to determine the need to initiate, continue, stop, or switch treatment for CNV. [21, 27, 29, 54, 55] 
Macular edema in retinal vein occlusions
This can present in the same way as DME except that the edema is usually segmental in a branch or tributary RVO. A higher incidence of serous retinal detachment is present in the acute phase and more of cystoid changes later. With increasing chronicity, schitic spaces may develop. [43, 44, 56] Macular edema in tumors SRF and CME can be seen on the surface of choroidal tumors and may cause a diagnostic dilemma if choroidal imaging is not performed. [57] [58] [59] 
Common Errors in Interpretation of Macular Edema

Macular schisis
In patients with X-linked retinoschisis, the schisis cavity can occur in a number of different layers of the neurosensory retina (RNFL, INL, and ONL/outer plexiform layer). In CME, it predominantly involves the inner nuclear and outer plexiform layers.
Retinoschisis in optic pit
The schisis is seen to extend till the optic disc margin and involves the outer plexiform layer. The optic pit can be seen on OCT with a vitreous tuft that may be associated. However, the most common associated finding is serous retinal detachment with outer lamellar holes. Additional cystic changes may be seen in the inner layers. These changes are seen to reverse with the occurrence of PVD which could be spontaneous or surgical. However, VMT is typically absent. [13, 42] 
Myopic foveoschisis
The split is seen as vertical pillars rather than oval well-defined spaces. This can be seen in the inner, middle, or outer retinal layers with combinations of the same. Associated features in myopic eyes are ILM detachment, ERMs, retinal microfolds, ellipsoid zone defects, paravascularmicroholes and macular holes, dome-shaped macula, and peripapillary intrachoroidal cavitations. [60] [61] [62] [63] Evaluation of a myopic eye is best done with SS-OCT as it has a wider field and greater depth, enabling better imaging of deep posterior staphylomas [ Fig. 16 ].
Outer retinal tubulation
ORT is seen as round or ovoid hyporeflective spaces with hyperreflective borders in the outer retina usually overlying areas of pigment epithelial atrophy or subretinal fibrosis. They are believed to represent degenerating photoreceptors and signify advanced disease. On cursory glance, they may appear as cystoid spaces, prompting unnecessary intervention as they have been shown to remain unchanged with treatment. [34] As measurements of central retinal thickness are easily done, this is probably the most common parameter used to study treatment outcomes. However, the correlation between central retinal thickness and best-corrected visual acuity (BCVA) is seen to vary between conditions. A recent analysis of clinical trial data of cases with neovascular AMD, DME, and RVO showed that at baseline, there was a small correlation between BCVA and central retinal thickness (CRT) in pooled AMD trial data, medium in pooled DME data and no correlation in pooled RVO data. At month 12, there was no correlation in AMD but medium correlation in DME and RVO data. Cases with recurrence in activity with shift to pro re nata (PRN) dosing showed correlation in AMD and RVO data. Overall, the best correlation was seen in DME indicating that in RVO and AMD, the relationship may be dependent on other factors as well. [24] 
Optical Coherence Tomography in Conditions Causing Serous Detachment at the Macula
Common conditions that cause serous detachment at the macula include CSCR, age-related macular degeneration, PCV, CNV complicating CSCR, pachychoroid neovasculopathy (Type 1 CNV with pachychoroid), dome-shaped macula with subfoveal detachment, optic disc pit, lupus erythematosus, choroidal ischemic disorders such as accelerated hypertension and preeclampsia, systemic corticosteroid usage, paraproteinemia, choroidal tumors, and in inflammatory disorders such as Harada's disease. [64, 65] 
Central serous chorioretinopathy
The characteristic OCT appearance is a localized detachment of the neurosensory retina typically at the macula.
The detached retina may be normal in acute cases; show intraretinal hyperreflective deposits in the ONL, OPL, ELM, and ellipsoid zone in chronic or recurrent cases; and may show thinning of the ONL, disruption of ELM, and ellipsoid zone in chronic cases. [66] Cystoid changes are a feature of chronicity [54] and may be seen in cases of more than 5 years duration.
The detached retina shows elongated photoreceptor segments which are a feature of most acute cases. [67] Subretinal hyperreflective deposits may be seen in long-standing cases and suggest a lower final visual acuity. The subretinal space may show moderate or highly reflective homogenous areas suggestive of fibrin with characteristic areas of clearing within them. [68, 69] The pigment epithelium may show single or multiple serous PEDs which could be a feature of acute, chronic, or inactive disease, microrips of the RPE [70] which suggest an active episode, RPE hypertrophy, or atrophy which are seen in chronic CSCR. The area of active leak may be seen either as a PED with a microrip, an area of RPE elevation or may be indicated by a sagging of the posterior layers of the detached retina toward an area of RPE elevation or detachment. [68] The bullous variant shows large RPE rips. [71] Choroidal imaging of almost all eyes with active CSCR as well as some asymptomatic fellow eyes shows subfovealchoroidal thickening and dilated choroidal vessels. [72] Chronic CSCR is believed to be part of the pachychoroid spectrum. Other features described include thinning of the inner choroidal vessels, focal choroidal excavation [73] [74] [75] (defined as a macular lesion with choroidal excavation detected on SD-OCT without evidence of scleral ectasia or posterior staphyloma), and loculation of fluid in the posterior choroid. [76] Fig. 17 shows the various OCT manifestations of CSCR.
Optical coherence tomography in Vogt-Koyanagi-Harada versus central serous chorioretinopathy
Common features are serous macular detachments and choroidal thickening. Features associated with CSCR are PED, Microrips of the RPE, RPE irregularity, fibrin with areas of echo lucency and large choroidal vessel dilatation. Features more suggestive of Vogt-Koyanagi-Harada (VKH) are subretinal septae, multiple pockets of SRF, RPE undulations, ILM irregularities and loss of reflectivity in the inner choroid, gross choroidal thickening with inability to visualize the choroidoscleral junction. [77] [78] [79] Retinal Pigment Epithelial Detachments Fig. 18 shows the OCT images of various types of PED.
Drusenoid pigment epithelial detachment
Drusenoid PEDs are a component of high risk AMD. They are seen as high reflective smooth or undulating elevations of the RPE . The sub RPE material is dense , homogeneous and of moderate to high reflectivity. Hyper reflective foci above the RPE indicate pigmentation. A small pocket of SRF over the PED is insignificant. Signs of associated CNV are intraretinal and/or SRF, heterogenous, or hyporeflective sub-RPE content. [31] Serous pigment epithelial detachment Well-demarcated highly reflective elevations of the RPE with the sub-RPE space being hyporeflective or optically empty. Long-standing cases may have hyperreflective foci on the surface indicating pigment clumping. Heterogeneous content of the PED indicates the presence of associated CNV. [31] Serous PED in CSCR is usually associated with underlying thickened choroid but may not be so in AMD. [64] 
Fibrovascular pigment epithelial detachment (vascularized pigment epithelial detachment) or Type 1 choroidal neovascularization
The content of the PED is either solid with lamellar structures and clefts or hyperreflective material stuck along the undersurface. Layered hyperreflective bands may be seen "the onion sign" -indicative of lipid exudation under the PED. [80] Pigment epithelial detachment in polypoidal choroidal vasculopathy Typically, hemorrhagic, serous, or a combination of the two, hemorrhagic PED is characterized by a very highly reflective thick elevation of the RPE with intense shadowing obscuring the details below it. The vascular complex or polyps can sometimes be seen as round or ovoid structures with variable hyporeflectivity in the center and a hyperreflective wall, on the undersurface of the PED. Occasionally, the polyp is seen to erode through the RPE into the subretinal space. SRF may be associated. The "triple layer sign" originally described in PCV but no longer considered pathognomonic consists of a triad of a PED, the lamellar scar and a second hyporeflective space or cleft is visualized immediately under it. [81] Pigment epithelial detachment in Type 3 choroidal neovascularization or retinal angiomatous proliferation OCT features are seen both above and below the RPE, which may be develop either simultaneously or sequentially in the course of progression. The evolution of the lesion has been described in three stages with typical OCT features which include a subtle irregular elevation of the RPE (erosion sign) or a frank PED associated with a localized discontinuity in the RPE (flap sign) through which a tubular continuous structure may be seen connecting the pre-and sub-RPE space and a focal funnel-shaped RPE joining an inverted funnel-shaped inner neuroepithelium ("kissing sign") over a large serosanguineous PED. The area over the PED may show ELM disruption, intraretinal edema, and CME, which is helps to differentiate Type 2 from Type 3 CNV. [82] Pigment epithelial detachments in central serous chorioretinopathy PEDs in CSCR, systemic conditions such as paraproteinemias, renal disease, inflammations, typically have a serous appearance. [65] Choroidal imaging and systemic evaluation help in the differentiation. PEDs in lymphomas have a high-reflective sub-RPE space.
Retinal pigment epithelium rip
Large PEDs with height >600 µ, diameter >5 mm are at risk of RPE tears. Signs of an impending rip in FVPED are folding and corrugation of the RPE with flattening of the PED because of contracture of the sub-PED neovascular membrane. [31] 
Choroidal Imaging
In conventional SD-OCT imaging systems, it is possible to image the choroid by shifting the zero delay line or point of highest sensitivity from its conventional location, more posteriorly toward the sclera. This technique called enhanced-depth imaging or EDI-OCT enables an overall assessment of the choroid and the choroidoscleral interface. [83] However, this technique does not significantly visualize the choriocapillaris or the choroidal microvasculature which are in close proximity to the RPE. The advantages of SS-OCT technology are higher imaging speed; higher detection efficiencies, improved imaging range, and reduced sensitivity roll off with increasing depth. These enable a better imaging of the internal structure of the choroid including the choriocapillaris and the choroidoscleral interface which is further enhanced by generating en face images as part of postacquisition image processing. [84, 85] Bhende, et al.: OCT interpretation of macular diseases The total choroidal thickness is defined as the distance between the outer aspect of the hyperreflective layer that corresponds to the RPE/Bruch membrane complex and the choroidoscleral interface. [84] The subfoveal choroidal thickness measurement though possible once the interfaces are identified is often a challenge. This is due to the high degree of variability in measurements even in normal subjects that includes variations with gender, age, race, refractive error, axial lengths, diurnal variation, and even the degree of accommodation. [86, 87] Differentiating the individual layers is not easy. The choriocapillaris is normally very strongly adherent to the Bruch's membrane. The extremely thin-walled nature and density again makes identification difficult though most suggest that it is represented by hyperreflective dots beneath the Bruch's membrane -RPE complex. Differentiation between the choriocapillaris and medium sized choroidal vessels is again difficult, but the larger choroidal vessels are easier to identify. As a general guide, the choriocapillaris is identified as a thin layer of moderate reflectivity in the space just adjacent to the RPE-Bruch's complex. The layer of medium choroidal vessels (Sattler's layer) is seen as a thick layer of round or oval hyporeflective spaces with hyperreflective margins in the middle choroid whereas the Haller's layer of large choroidal vessels is formed by larger oval hyporeflective spaces in the outer choroid adjacent to the homogenous band that represents the choroidoscleral interface. [10] Noninvasive choroidal imaging with OCT has increased our understanding of the role of the choroid in various disease conditions.
Age-related macular degeneration
In eyes with early or intermediate AMD, no consistent choroidal thickness abnormalities have been noted, but many studies have shown thinning of the choroid in eyes with advanced AMD compared to age-matched controls. However, in eyes with reticular pseudodrusen, diffuse choroidal thinning, and lack of choriocapillaris has been demonstrated, as also in a newly described entity called age-related choroidal atrophy. [88] Polypoidal choroidal vasculopathy The subfoveal total choroidal thickness is increased in PCV, compared to typical AMD, in both affected and asymptomatic contralateral eyes, even after adjustment for age, gender, and refractive error. [37] However, a recent study has shown a subset of eyes with typical PCV having a normal or thinner than normal choroid.
Central serous chorioretinopathy
The role of the choroid is being increasingly noted in this condition with the subfoveal total choroidal thickness being increased almost universally in CSCR. [64] It is seen to be thickened in even the apparently uninvolved fellow eye in some series. Focal or diffuse dilatation of the choroidal vessels has also been seen on enface OCT images though its exact relevance remains unclear. Thickness of the choroid is seen to reduce with treatments such as photodynamic therapy (PDT), oral acetazolamide, and anti-VEGF agents, but the thickness always remains above normal.
Pachychoroid
This is a relatively recently described entity characterized by an abnormal and permanent increase in choroidal thickness, associated with dilated choroidal vessels and other structural alterations of the normal choroidal architecture. The spectrum includes pachychoroid pigment epitheliopathy, CSCR, pachychoroid neovasculopathy, and PCV. [38] [39] [40] Typically, the larger choroidal vessels are dilated, and in these areas, the choriocapillaries and Sattler's layer are compressed or obliterated. The overlying RPE may show irregularities, a Type 1 CNV or polypoidal lesion may be seen.
Uveitis
EDI and SS-OCT imaging has generated a better understanding of choroidal changes in eyes with posterior uveitis. [89, 90] In the acute phase of VKH, the subfoveal choroid is seen to be diffusely thickened with loss of the hyperreflective dots in the inner choroid that indicates inflammation. [79] The RPE layer can appear to have a bumpy surface, especially in eyes with severe exudative retinal detachment (RD). Occasionally, the thickening of the choroid is so significant that the choroidoscleral junction is not apparent. However, with initiation of treatment, the choroidal thickness is seen to reduce. In eyes with chronic disease and depigmentation, the choroid is significantly thinner than normal. A more significant use of choroidal imaging is the detection of choroidal thickening in an eye that appears to be in the quiescent stage. [91] This finding suggests persistent subclinical inflammation and warrants additional investigations. It has also be shown to detect rebound choroidal thickness described as an increase of more than 100 microns in the absence of other clinical signs of inflammation [ Fig. 19 ].
Eyes with birdshot chorioretinopathy and Behcet's disease have choroidal thinning. [92, 93] Choroidal imaging has made it possible to characterize choroidal granulomas which are seen as localized low-reflective areas within the choroid. Serial OCTs can be used to monitor the response to therapy. [94, 95] In eyes with posterior scleritis, the choroid may be significantly thickened and it may be difficult to visualize Volume 66 Issue 1 2. Is the scan protocol used appropriate for the information required?
3. Is the scan quality good enough for analysis? Identify artifacts, other findings that could affect image quality 4. Use the Macular cube, 3D, or volume scans for evaluation of the pathology in toto, including the segment maps. Color or grayscale images are both adequate 5. Look at the macular thickness map and ETDRS grid and get an idea as to the location of the pathology. Ensure that the overlay of the thickness map is centered on the fovea in the color, SLO, or IR image 6. Evaluate each layer from the posterior vitreous to the choroidoscleral junction if visible, for deviation from the normal. The HD 5 line raster scans or line scans are preferable for this as they scan a precise location and have a higher resolution. Grayscale images are preferable 7. Classify the abnormality into one or more of the following: change in contour, change in thickness, change in reflectivity, loss of tissue, presence of abnormal tissue. Look for the location of the abnormality, layers involved either primarily or as part of secondary effects 8. Take measurements as appropriate in addition to the standard thickness measurements that are inbuilt in the protocols. In case of follow-up scans, use software to analyze change 9. Advanced analysis such as en face OCT images can be generated in selected instances 10. Look for the presence of known biomarkers before making the final diagnosis OCT: Optical coherence tomography, ETDRS: Early treatment diabetic retinopathy study, SLO: Scanning laser ophthalmoscopy, HD: High definition, 3D: Three-dimensional, IR: Infrared the choroidoscleral junction in the acute phase, but with repeated episodes of scleritis, significant thinning of the choroid is seen.
Choroidal and retinal tumors
EDI and SS-OCT give valuable information in retinal and small choroidal tumors that cannot be characterized on conventional ultrasound. In addition to overlying retinal changes that are secondary to the tumor, the surface as well as intralesional characteristics of most of the common retinal and choroidal tumors are better understood. [57] [58] [59] Contour abnormalities of the choroid and sclera are well seen using EDI and SS OCT, and even more so in high myopia where the penetration is deeper due to the thinner choroid and relatively depigmented RPE. These include posterior staphyloma, [96] [97] [98] dome-shaped macula. [60, [99] [100] [101] peripapillary and macular intrachoroidal cavitations, [61, 62] and optic pits and colobomas [102] [103] [104] Table 5 is a short summary of the steps involved in the interpretation of an image on OCT.
Conclusion
OCT is a noninvasive, quick, and reproducible investigation that has revolutionized the imaging of posterior segment lesions. Correlation of individual layers involved on OCT with histopathology has brought us much closer to an accurate tissue diagnosis than ever before. Various combinations of findings on OCT and comparison with known OCT-based biomarkers have made disease identification and prognostication much simpler. The development of standardized protocols for imaging and measuring specific areas and software to ensure repeated evaluation of the same point at different time frames, it is possible to collect and reliably evaluate large data for multicentric trials. Automated image analysis of known OCT biomarkers for AMD is aimed at simplifying quantification of these biomarkers, thereby helping in grading of large data. [105] Newer developments with the technology include intraoperative OCT, [106, 107] ultra-wide field OCT, [108] OCT Angiography and its newer algorithms including optical microangiography, speckle variance, phase variance, split-spectrum amplitude-decorrelation angiography, and correlation mapping, [109] and adaptive optics OCT. [110] These would further enhance understanding of both anatomical and functional aspects of retinal pathology.
